| Triston Dale Brownfield, RPH | |
|
1 S Keene St, Columbia, MO 65201-7199 | |
| (573) 876-8410 | |
| Not Available |
| Full Name | Triston Dale Brownfield |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 S Keene St, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013927417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 044803 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Triston Dale Brownfield, RPH 1 S Keene St, Columbia, MO 65201-7199 Ph: (573) 876-8410 | Triston Dale Brownfield, RPH 1 S Keene St, Columbia, MO 65201-7199 Ph: (573) 876-8410 |
News Archive
A research group led by scientists from the RIKEN Center for Advanced Intelligence Project have developed a novel system that can automatically detect abnormalities in fetal hearts in real-time using artificial intelligence.
Research management experts from across federal science agencies will gather in Washington, D.C., Oct. 28-29, to discuss approaches for identifying research priorities, exploring research performance management, and assessing the impact of completed research.
The Center of Innovation for Nanobiotechnology (COIN) today announced the upcoming NanoBio Executive Roundtable event to be hosted at RTP Foundation in Durham, NC on May 17, 2011. This Roundtable will tackle regulatory issues surrounding nanomedicine commercialization. The "Nanomedicines and the Regulatory Path" Roundtable will kick off with a presentation from Katherine Tyner, Ph.D., a Chemist in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
› Verified 1 days ago
Ms. Chunhan H Ma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Brooke Stiles, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Winding Wood Ct, Columbia, MO 65203 Phone: 573-355-6079 | |
Mrs. Debra Denise Tesoro, RPH, BCOP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 E. Broadway, Suite 100, Columbia, MO 65201 Phone: 573-817-8527 Fax: 573-449-4246 | |
Dr. Carolin G Gatzke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 222 E Broadway, Columbia, MO 65203 Phone: 573-874-3562 | |
Brittney Houston, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Ashley Nixon-mongler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1814 Paris Rd, Columbia, MO 65201 Phone: 573-777-7373 Fax: 573-777-7374 | |
Lee Ann Lawson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 S Fairview Rd, Columbia, MO 65203 Phone: 573-884-1101 Fax: 573-884-1103 |